| Financial Year |
March 31 2023 |
| Monetary Funds |
454,038,162.26 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
45,367,343.01 |
| Accounts Receivable |
271,617,959.39 |
| Advances to Suppliers |
7,557,851.87 |
| Other Receivables |
3,541,057.37 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
300,260,598.85 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
9,363,599.52 |
| Total Current Assets |
1,110,760,205.32 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
10,457,112.21 |
| Investment Properties |
21,858,277.41 |
| Fixed Assetes |
111,177,565.08 |
| Under-construction Projects |
25,098,931.01 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
16,088,515.41 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
17,123,007.83 |
| Deferred Income Tax Assets |
8,333,609.04 |
| Other Non-Current Assets |
486,970.11 |
| Sub-Total of Non-Current Assets |
285,719,874.88 |
| Total Assets |
1,396,480,080.20 |
| Short-Term Loans |
10,330,581.62 |
| Trading Financial liabilities |
775,763.98 |
| Notes Payable |
35,404,665.90 |
| Accounts Payable |
58,716,507.77 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
11,274,495.12 |
| Taxes Payable |
727,298.34 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
17,215,301.90 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,774,958.39 |
| Other Current Liabilities |
5,180,991.60 |
| Sub-Total of Current Liabilities |
149,869,760.85 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
122,521.64 |
| Deferred Income Tax Liabilities |
1,607,523.85 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
9,349,912.06 |
| Total Liabilities |
159,219,672.91 |
| Paid-In Capital(Or Share Stock) |
259,923,971.00 |
| Capital Surplus |
453,494,362.71 |
| Surplus Reserve |
24,543,119.08 |
| LESS:Treasury Stock |
29,997,374.69 |
| Undistributed Profits |
527,440,923.38 |
| Minority Stockholder's Interest |
382,084.85 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,236,878,322.44 |
| Owner's Equity（Stockholder's Equity） |
1,237,260,407.29 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,396,480,080.20 |
